Treatment of onychomycosis with oral antifungal agents

Bibliography

• FAERGEMANN J, BARAN R: Epidemiology, clinical presentation and diagnosis of onychomycosis. Br. J. Dermatol. (2003) 149(Suppl. 65):1–4
   PubMed Web of Science ®Google Scholar
• •A good review on onychomycosis
   Google Scholar
• TOSTI A, PIRACCINI BM, LORENZI S: Onychomycosis caused by nondermatophytic molds: clinical features and response to treatment of 59 cases. J. Am. Acad. Dermatol. (2000) 42:217-224. A good review on epidemiology, clinical features and response to treatment of NDMs onychomycosis
   Google Scholar
• KENNA ME, ELEWSKI BE: A US epidemiological survey of superficial fungal diseases. J. Am. Acad. Dermatol. (1996) 35:539–542
   PubMed Web of Science ®Google Scholar
• HANEKE E: Fungal infections of the nail. Sem. Dermatol. (1991) 10:41–53
   PubMedGoogle Scholar
• MAHONEY JM, BENNET J, OLSEN B: The diagnosis of onychomycosis. Dermatol. Clin. (2003) 21(3):463–467
   PubMed Web of Science ®Google Scholar
• GEYER AS, ONUMAH N, UYTTENDAELE H, SCHER RK: Modulation of linear nail growth to treat diseases of the nails. J. Am. Acad. Dermatol. (2004) 50:229–234
   PubMed Web of Science ®Google Scholar
• ZAIAS N, TOSTI A, REBELL G et al.: Autosomal dominant pattern of distal subungual onychomycosis caused by Trichophyton rubrum. J. Am. Acad. Dermatol. (1996) 34:302–304
   PubMed Web of Science ®Google Scholar
• ZAIAS N: Onychomycosis. In: The Nail in Health and Disease (2nd Edition). Appleton & Lange, Norwalk, CT, USA (1990) 87–105
   Google Scholar
• BARAN R, HAY RJ, TOSTI A, HANEKE E: A new classification of onychomycosis. Br. J. Dermatol. (1998) 139(4):567–571
   PubMed Web of Science ®Google Scholar
• •Describes the different clinical patterns of infection by which fungi colonise the nail
   Google Scholar
• DANIEL CR III, NORTON LA, SCHER RK: The spectrum of nail disease in patients with human immunodeficiency virus infection. J. Am. Acad. Dermatol. (1992) 27:93–97
   PubMed Web of Science ®Google Scholar
• GUPTA AK, LYNCH LE: Onychomycosis: review of recurrence rates, poor prognostic factors, and strategies to prevent disease recurrence. Cutts (2004) 74(Suppl. 1):10–15
   PubMed Web of Science ®Google Scholar
• PIRACCINI BM, TOSTI A: White superficial onychomycosis: epidemiological, clinical, and pathological study of 79 patients. Arch. Dermatol. (2004) 140(6):696–701
   PubMed Web of Science ®Google Scholar
• ••An excellent review of white superficialonychomycosis revisited
   Google Scholar
• BARAN R, HAY R, PERRIN C: Superficial white onychomicosis revisited. J. Eur. Acad. Dermatol. VenereoL (2004) 18:569–571
   PubMed Web of Science ®Google Scholar
• BARAN R: Nail fungal infections and treatment. Hand Clin. (2002) 18(4):625–628
   PubMed Web of Science ®Google Scholar
• DARKES MJ, SCOTT LJ, GOA KL: Terbinafine: a review of its use in onychomycosis in adults. Am. J. Clin. Dermatol. (2003) 4(1):39–65
   PubMed Web of Science ®Google Scholar
• TOSTI A, PIRACCINI BM, STINCHI C,, et al.: Treatment of dermatophyte nail infections: an open randomized study comparing intermittent terbinafine therapy with continuous terbinafine treatment and intermittent itraconazole therapy. J. Am. Acad. Dermatol. (1996) 34(4):595–600
   PubMed Web of Science ®Google Scholar
• PAVLOTSKY F, ARMONI G, SHEMER A, TRAU H: Pulsed versus continuous terbinafine dosing in the treatment of dermatophyte onychomycosis. J. Dermatol. Twat. (2004) 15:315–320
   PubMedGoogle Scholar
• ZAIAS N, REBELL G: The successful treatment of Trichophyton rubrum nail bed (distal subungual) onychomycosis with intermittent pulse-dosed terbinafine. Arch. Dermatol. (2004) 140(6):691–695
   PubMed Web of Science ®Google Scholar
• •This paper evaluates the effectiveness of intermittent administration of oral terbinafine to cure DSO and the maximum effective treatment interval
   Google Scholar
• GUPTA AK, SKINNER AR: Onychomycosis in children: a brief overview with treatment strategies. Pediatr. Dermatol. (2004) 21(1):74–79
   PubMed Web of Science ®Google Scholar
• GUPTA AK, KATZ HI, SHEAR NH: Drug interactions with itraconazole, fluconazole, and terbinafine and their management. J. Am. Acad. Dermatol. (1999) 41(2 Pt 1):237–249
   PubMed Web of Science ®Google Scholar
• ••A detailed review on drug interactions withsystemic antifungals
   Google Scholar
• DEBRUYNE D, COQUEREL A: Pharmacokinetics of antifungal agents in onychomycoses. Clin. Pharmacoki net. (2001) 40(6):441–472
   PubMed Web of Science ®Google Scholar
• ODOM RB, ALY R, SCHER RK et al: A multicenter, placebo-controlled, double-blind study of intermittent therapy with itraconazole for the treatment of onychomycosis of the fingernail. J. Am. Acad. Dermatol. (1997) 36(2 Pt 1):231–235
   PubMed Web of Science ®Google Scholar
• DRAKE L, BABEL D, STEWART DM et al.: Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the fingernail. J. Am. Acad. Dermatol. (1998) 38(6 Pt 2):587–594
   Google Scholar
• SCHER RK, BRENEMAN D, RICH P et al.: Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail. J. Am. Acad. Dermatol. (1998) 38(6 Pt 2):577–586
   Google Scholar
• TOSTI A, PIRACCINI BM, IORIZZO M: Management of onychomycosis in children. Dermatol. Clin. (2003) 21(3):507–509
   PubMed Web of Science ®Google Scholar
• ••Reviews the management of onychomycosis in children and treatment strategies
   Google Scholar
• EPSTEIN E: How often does oral treatment of toenail onychomycosis produce a disease free nail? Arch. Dermatol. (1998) 134:1551–1554
   Web of Science ®Google Scholar
• GUPTA AK, RYDER JE, JOHNSON AM: Cumulative meta-analysis of systemic antifungals agents for the treatment of onychomycosis. Br. J. Dermatol. (2004) 150:537–544
   PubMed Web of Science ®Google Scholar
• SCHER RK, BARAN R: Onychomycosis inclinical practice: factors contributing to recurrence. Br. J. Dermatol (2003) 149\(Suppl. 65):5–9
   PubMed Web of Science ®Google Scholar
• BARAN R, DE DONCKER P: Lateral edge nail involvement indicates poor prognosis for treating onychomycosis with the new systemic antifungals. Acta Derm. Venereol. (1996) 76:82–83
   PubMed Web of Science ®Google Scholar
• ROBERTS DT, EVANS EG: Subungual dermatophytoma complicating dermatophyte onychomycosis. Br. J. Dermatol. (1998) 138:189–190
   PubMed Web of Science ®Google Scholar
• GUPTA AK, LYNDE CW, KONNIKOV N: Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis. J. Am. Acad. Dermatol (2001) 44(3):485–491
   PubMed Web of Science ®Google Scholar
• •Useful comparison between sequential treatment and pulse therapy
   Google Scholar
• GUPTA AK, KONNIKOV N, LYNDE CW: Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly./ Am. Acad. Dermatol. (2001) 44:479–484
   PubMed Web of Science ®Google Scholar
• TOSTI A, PIRACCINI BM, LORENZI S, IORIZZO M: Treatment of nondermatophyte mold and Candida onychomycosis. Dermatol Clin. (2003) 21(3):491–497
   PubMed Web of Science ®Google Scholar
• •A practical update on treatment strategies
   Google Scholar
• GIANNI C, ROMANO C: Clinical and histological aspects of toenail onychomycosis caused by Aspergillus spp.: 34 cases treated with weekly intermittent terbinafine. Dermatology. (2004) 209:104–110
   PubMed Web of Science ®Google Scholar
• TOSTI A, PIRACCINI BM, GHETTI E, COLOMBO MD: Topical steroids versus systemic antifungals in the treatment of chronic paronychia: an open, randomized double-blind and double dummy study. J. Am. Acad. Dermatol (2002) 47(1):73–76
   PubMed Web of Science ®Google Scholar
• TOSTI A, PIRACCINI BM: Paronychia.In: Contact Urticaria Syndrome. CRC Press, Boca Raton, NY, USA (1997) 267–278
   Google Scholar
• GUPTA AK, RYDER JE: The use of oral antifungal agents to treat onychomycosis. Dermatol. Clin. (2003) 21(3):469–479
   PubMed Web of Science ®Google Scholar
• TOSTI A, PIRACCINI BM, STINCHI C, COLOMBO MD: Relapses of onychomycosis after successful treatment with systemic antifungals: a three-year follow-up. Dermatology (1998) 197(2):162–166
   PubMed Web of Science ®Google Scholar
• GUPTA AK, RYDER JE: How to improve cure rates for the management of onychomycosis. Dermatol Clin. (2003) 21(3):499–505
   PubMed Web of Science ®Google Scholar